MIR4730

Across TCGA pan-cancer cohorts, MIR4730 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated MIR4730 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher MIR4730 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MIR4730 expression acts as an unfavorable survival marker, although some lineages such as UCS and BRCA show a favorable association.

UCS, KIRC, and BRCA are the cancer types where MIR4730 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Median	II,III,IV	0.704	0.276	<.001	142	view →
KIRC	DFS	Tertile	All	0.524	0.757	<.001	78	view →
BRCA	OS	Tertile	II,III,IV	0.980	0.937	.001	67	view →
BLCA	DFS	Quartile	III,IV	0.665	0.499	.005	31	view →
PAAD	DFS	Tertile	All	0.617	0.373	.004	30	view →
PRAD	DFS	Median	All	0.833	0.927	<.001	18	view →
SKCM	OS	Tertile	II,III,IV	0.557	0.322	.009	18	view →
THCA	OS	Median	II,III,IV	0.333	0.964	.023	16	view →
SARC	DFS	Tertile	All	0.774	0.547	<.001	16	view →
COAD	OS	Quartile	II,III,IV	0.634	0.823	.007	13	view →
CESC	OS	Median	IV	0.629	0.180	.029	12	view →
KIRP	DFS	Tertile	IV	0.311	0.661	.029	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

MIR4730–UCS (OS)

Open the UCS breakdown →